Socrus Bio Sciences Ltd Stock Analysis

BSE: 524719 | NSE: | Hospital & Healthcare Services | Small Cap

BSE Share Price
Not Listed

DeciZen - Make an Informed Decision on Socrus Bio Sciences

M-Cap below 100cr DeciZen not available


1. Is Socrus Bio Sciences Ltd. a good quality company?

Data is not available for this company.

2. Is Socrus Bio Sciences Ltd. undervalued or overvalued?

No data found

3. Is Socrus Bio Sciences Ltd. a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Socrus Bio Sciences Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Socrus Bio Sciences:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide
ROCE % 0.6%-0.5%0.4%-3%0.3%0.7%0.3%19.5%13.5%-137.4%-

Growth Parameters

Growth Parameters Colour Code Guide
Sales 36.811.432.811.
YoY Gr. Rt. %--69.1%188.3%-64.5%-18.4%-44.1%7.1%287.4%36.6%-34.1%-
Adj EPS 0.1-0.10-1.2-
YoY Gr. Rt. %--216.7%NA-11900%NANA-72.2%2780%11.1%-662.5%-
BVPS (₹)
Adj Net Profit 0.1-0.10-1.7-
Cash Flow from Ops. -1.6-7.9-5.1-51.4-2.2-4.9703.3-0.1-3.3-
Debt/CF from Ops. -0.1-1-2.7-1.3-30.1-14.20000-


CAGR Colour Code Guide
9 Years 5 Years 3 Years 1 Years
Sales -6.6%15.9%51.7%-34.1%
Adj EPS -274.5%NA-664.6%-662.5%
BVPS -30-45-63.3-96.9
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide
Return on Equity % 0.6-0.70.1-12.8-
Op. Profit Mgn % 0.4-1.4-2.7-24.7-1-6.2-2.218.921.4-100.3-9.8
Net Profit Mgn % 0.2-0.90.1-14.8-
Debt to Equity 00.615.25.75.90000-
Working Cap Days 1205032671,6302,8915,2992,8611691701740
Cash Conv. Cycle 76282922312484694391181221210

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to %

Sales growth has been subdued in last 3 years %

Sales growth is not so good in last 4 quarters at %

Latest Financials - Socrus Bio Sciences Ltd.

Standalone Consolidated
TTM EPS (₹) -0 -
TTM Sales (₹ Cr.) 1.2 -
BVPS (₹.) 0.4 -
Reserves (₹ Cr.) -31 -
P/BV 1.10 -
PE 0.00 -
From the Market
52 Week Low / High (₹) 0.48 / 0.49
All Time Low / High (₹) 0.48 / 24.00
Market Cap (₹ Cr.) 1.5
Equity (₹ Cr.) 32
Face Value (₹) 10
Industry PE 77.6

Management X-Ray of Socrus Bio Sciences :

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *
* Pledged shares as % of Promoter's holding (%)

Event Update

Analyst's Notes


About Socrus Bio Sciences Ltd

Socrus Bio Sciences is engaged in the agro biotech business in India. It offers natural remedies for various indications under the Agnihotri brand name.

The company’s products include piles clear, kabj rahat churan, madhushala amrut, pens stick, glucose, lal dant manjan, burn-nil, heal-up, BDK tablets, pimple clear gels, jatamansi tel, antiseptic lotion, kali mirch, budhivardhak tel, M.K.C.K goli, and P.J. capsules.

The company, was formerly known as Tanu Health Care, is based in Mumbai, India.

The registered office is located at 30, 16-A, PMGP Colony, Mahakali Cave Road, MIDC, Andheri (East), Mumbai - 400 093, Maharashtra.

Read More Read Less